Mike Davies
Founder & Chief Executive Officer Carocell Bio Ltd.
I am the CEO and Founder of Carocell Bio (“Carocell”) who are developing novel peptides with nano-particle medicines to safety treat inflammatory diseases, such as atopic dermatitis (AD) / eczema, adenocarcinoma of the lung, and neuro-inflammation.
Seminars
Thursday 21st May 2026
Panel Discussion: Leveraging Cross-Sector Partnerships: How Small Biotechs Navigate Big Pharma Interest in Dermatology
2:00 pm
- What data packages de-risk acquisition or licensing for large pharma?
- How do biotechs time interactions with BD teams and investment banks?
- What distinguishes “interesting science” from investable clinical programs?
